Glypicans constitute a family of heparan sulfate proteoglycans (HSPGs) that are connected to the exocytoplasmic domain of the cell membrane by a glycosyl-phosphatidylinositol (GPI) anchor, and, to-date, several members of the glypican family, specifically six in mammals (GPC1-GPC6) and two in Drosophila, have been identified (3, 4) (Table 1) .
Reports connecting GPC1 associated to PC begin almost 15 years ago, when Kleeff and co-authors documented that GPC1 is over-expressed in human PC and in adjacent stroma fibroblasts, its antisense strikingly decreases the tumorigenicity of PC cells, and GPC1 itself plays an important role in the response to several mitogenic stimuli, such as HB-EGF (5, 6) and FGF-2 (5) (6) (7) .
Moreover, the same group later documented that in PC cells, GPC1 is required for an efficient TGF-β1 signaling (8) . It was later shown that GPC1 down-regulation suppresses PC cell growth and slightly modifies signaling of members of the TGF-β family (9) .
Exosomes
Extracellular vesicles (EV) family includes exosomes, microvesicles and a variety of vesicles released by many cellular types (10) (11) (12) .
Literature reports a growing body of evidence suggesting that cancer cells release more EV than normal ones, partly in relation to the response of a number of oncogenes, including e.g., ras (2, (13) (14) (15) (16) .
The term exosome was firstly used in 1981 to describe membrane-enclosed structures of 40 to 500-1,000 nm in diameter that had been 'exfoliated' from the surface of cultured cells (17) . The same term was proposed in 1987 for 50-100 nm vesicles that form inside endosomes, and that are released in the extracellular compartment when endosomes fuse with the cellular membrane (18) . Opposite, microvesicles are >1,000 nm and bud directly from plasma membrane (19) .
EVs circulate in the blood, urine, ascites, and cerebrospinal fluid (20) (21) (22) (23) , also in cancer patients: indeed, circulating EVs have been detected in the blood samples of patients with glioblastoma, colorectal, ovarian and nonsmall cell (NSC) lung cancer (24) (25) (26) (27) .
Analysis of exosomes could be highly significant,
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Glypican-1 exosomes: do they initiate a new era for early pancreatic cancer diagnosis? since they contain proteins, nucleic acids (coding-and non-coding RNAs and DNAs), thus it can provide information on the primary tumor and along with its microenvironment (28) (29) (30) .
The main functions of exosomes in cancer microenvironment are to promote cancer growth, to stimulate the angiogenesis, to activate stromal fibroblasts, to sculpture cancer extracellular matrix, to generate pre-metastatic niche and to suppress the host immune responses (31) .
Their laboratory detection could be, however, challenging, mostly due to their small size that often involves several ultracentrifugations cycles, in order to concentrate a large volume and amount of material. To address these technological challenges, a series of miniaturized systems have been developed to facilitate exosome analyses including microfluidic enrichment and magnetic detection (32) .
Circulating glypican-1 (GPC1) exosomes in pancreatic cancer (PC)
Melo and co-authors recently reported the detection of circulating exosomes in breast, PC patients, as well as healthy donors (2) . The investigation required several labbases analyses, as isolation of EVs by ultra-centrifugation, NanoSight nanoparticle tracking and transmission electron microscopy (TEM); proteins were evaluated by ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) and GPC1 was detected exclusively in cancer exosomes using immunogold-TEM and immunoblot.
This case-control translational study revealed that the overall concentration of exosomes in cancer patients and the concentration of circulating GPC1 EVs in PCs were significantly higher comparing controls. Furthermore, circulating GPC1 EVs of PC patients harbor K-ras mutations in 65.9% of the cases (31 out of 47 PC analyzed) (Figure 1) .
On the same extent, the main and innovative finding reported in this paper was the striking perfection of ROC curve analysis when analyzing the concentration of GPC1 exosomes for distinguishing cancer from benign diseases and cancer in situ from advantages stages in a clinical series of patients, as well as pre-malignant lesions (PanIN) from PC in a mice model (AUC 1.0).
Of note, neither the size nor the overall concentration of circulating exosomes were documented valid, and also Ca19.9 was proven inferior comparing GPC1 exosomes, suggesting these latter as a peculiar hallmark of PC, suitable also as candidates for early detection.
The primary application could be screening of PanIN patients, although human data should be advocated. It has been documented that K-ras are the driver mutations for PC and are detected in early PanIN-1, but it requires 15-20 years for this lesion to progress into metastatic PC (33) (34) (35) , thus un-invasive monitoring of these patients could be extremely useful. Other translational uses could be the screening of circulating GPC1 exosomes in selected risk categories of patients, as alcoholics, obese, chronic pancreatitis or patients presenting a familial risk.
Another important clinical use could be the prediction of survival of PC patients, indeed Melo and associates, using a Cox multivariate regression analysis documented that the decrease of circulating GPC1 exosomes as an independent prognostic marker predictive for disease-specific survival. This result confirms previous finding by Duan and coauthors, who reported that GPC1 is significantly related to the perineural invasion in PC and it has an independent prognostic effect on the overall survivals (36) .
Conclusions
Undoubtedly Melo findings should be confirmed in larger series of patients, but the striking laboratory evidences provided in this paper could open and promote (from bench to bed) a new prospective era for early PC detection.
